Benjamin F. Edwards & Company’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $6.27M | Buy |
11,337
+172
| +2% | +$98.5K | 0.11% | 195 |
|
|
2024
Q1 | $6.49M | Sell |
11,165
-294
| -3% | -$165K | 0.12% | 189 |
|
|
2023
Q4 | $6.08M | Buy |
11,459
+1,279
| +13% | +$619K | 0.12% | 182 |
|
|
2023
Q3 | $5.15M | Sell |
10,180
-348
| -3% | -$185K | 0.2% | 108 |
|
|
2023
Q2 | $5.49M | Sell |
10,528
-20
| -0.2% | -$10.8K | 0.21% | 103 |
|
|
2023
Q1 | $6.08M | Sell |
10,548
-441
| -4% | -$249K | 0.25% | 88 |
|
|
2022
Q4 | $6.05M | Buy |
10,989
+1,796
| +20% | +$952K | 0.27% | 87 |
|
|
2022
Q3 | $4.66M | Sell |
9,193
-43
| -0.5% | -$24.1K | 0.23% | 100 |
|
|
2022
Q2 | $5.02M | Buy |
9,236
+25
| +0.3% | +$13.8K | 0.24% | 100 |
|
|
2022
Q1 | $5.44M | Buy |
9,211
+918
| +11% | +$527K | 0.24% | 99 |
|
|
2021
Q4 | $5.53M | Buy |
8,293
+135
| +2% | +$84.3K | 0.25% | 92 |
|
|
2021
Q3 | $4.66M | Buy |
8,158
+270
| +3% | +$148K | 0.23% | 97 |
|
|
2021
Q2 | $3.98M | Buy |
7,888
+25
| +0.3% | +$11.8K | 0.2% | 118 |
|
|
2021
Q1 | $3.59M | Buy |
7,863
+264
| +3% | +$126K | 0.19% | 129 |
|
|
2020
Q4 | $3.54M | Buy |
7,599
+122
| +2% | +$57.2K | 0.21% | 121 |
|
|
2020
Q3 | $3.3M | Sell |
7,477
-302
| -4% | -$125K | 0.22% | 114 |
|
|
2020
Q2 | $2.82M | Sell |
7,779
-1,635
| -17% | -$548K | 0.2% | 122 |
|
|
2020
Q1 | $2.67M | Buy |
9,414
+78
| +0.8% | +$24.6K | 0.23% | 109 |
|
|
2019
Q4 | $3.03M | Sell |
9,336
-80
| -0.8% | -$24.3K | 0.21% | 115 |
|
|
2019
Q3 | $2.74M | Buy |
9,416
+412
| +5% | +$118K | 0.21% | 120 |
|
|
2019
Q2 | $2.64M | Buy |
9,004
+171
| +2% | +$47.1K | 0.22% | 110 |
|
|
2019
Q1 | $2.42M | Buy |
8,833
+510
| +6% | +$127K | 0.22% | 114 |
|
|
2018
Q4 | $1.86M | Buy |
8,323
+1,124
| +16% | +$264K | 0.19% | 124 |
|
|
2018
Q3 | $1.76M | Buy |
7,199
+1,741
| +32% | +$401K | 0.17% | 140 |
|
|
2018
Q2 | $1.13M | Buy |
5,458
+872
| +19% | +$185K | 0.11% | 190 |
|
|
2018
Q1 | $947K | Buy |
4,586
+103
| +2% | +$21.6K | 0.1% | 216 |
|
|
2017
Q4 | $851K | Buy |
4,483
+257
| +6% | +$49.2K | 0.09% | 233 |
|
|
2017
Q3 | $800K | Buy |
4,226
+165
| +4% | +$29.9K | 0.1% | 210 |
|
|
2017
Q2 | $709K | Buy |
4,061
+645
| +19% | +$108K | 0.09% | 217 |
|
|
2017
Q1 | $525K | Buy |
3,416
+60
| +2% | +$9.17K | 0.08% | 251 |
|
|
2016
Q4 | $474K | Buy |
3,356
+340
| +11% | +$50.1K | 0.08% | 254 |
|
|
2016
Q3 | $480K | Buy |
3,016
+304
| +11% | +$46.8K | 0.08% | 230 |
|
|
2016
Q2 | $401K | Hold |
2,712
| – | – | 0.08% | 237 |
|
|
2016
Q1 | $384K | Hold |
2,712
| – | – | 0.08% | 229 |
|
|
2015
Q4 | $385K | Hold |
2,712
| – | – | 0.08% | 223 |
|
|
2015
Q3 | $332K | Hold |
2,712
| – | – | 0.07% | 242 |
|
|
2015
Q2 | $352K | Buy |
2,712
+45
| +2% | +$5.87K | 0.07% | 255 |
|
|
2015
Q1 | $358K | Hold |
2,667
| – | – | 0.08% | 241 |
|
|
2014
Q4 | $334K | Buy |
2,667
+100
| +4% | +$12.2K | 0.08% | 243 |
|
|
2014
Q3 | $312K | Hold |
2,567
| – | – | 0.08% | 243 |
|
|
2014
Q2 | $303K | Hold |
2,567
| – | – | 0.08% | 236 |
|
|
2014
Q1 | $309K | Hold |
2,567
| – | – | 0.08% | 215 |
|
|
2013
Q4 | $286K | Hold |
2,567
| – | – | 0.1% | 202 |
|
|
2013
Q3 | $237K | Buy |
2,567
+880
| +52% | +$79.6K | 0.09% | 207 |
|
|
2013
Q2 | $143K | Buy |
+1,687
| New | +$140K | 0.06% | 245 |
|
Other funds holding TMO
Benjamin F. Edwards & Company's TMO Position: Q2 2024 in Review
Benjamin F. Edwards & Company increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q2 2024, buying an estimated $98.5K and bringing the position to 11,337 shares worth $6.27M. The position accounts for 0.11% of the portfolio, ranked #195.
Benjamin F. Edwards & Company first reported a position in TMO in Q2 2013 and has held it in 45 quarters since. The position peaked at $6.49M in Q1 2024. 2,543 funds tracked by Wall St. Rank hold TMO as of Q2 2024.
- Benjamin F. Edwards & Company held 11,337 shares of Thermo Fisher Scientific worth $6.27M as of Q2 2024.
- Benjamin F. Edwards & Company bought 172 Thermo Fisher Scientific shares in Q2 2024, an estimated $98.5K.
- Thermo Fisher Scientific made up 0.11% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #195 holding.
- Benjamin F. Edwards & Company first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 45 quarters since.
- Benjamin F. Edwards & Company's Thermo Fisher Scientific position peaked at $6.49M in Q1 2024.
- 2,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.